Factors Affecting Burden of Psychopharmacological Medication in Patients with Autism Spectrum Disorder: The Importance of Early Diagnosis

Yükleniyor...
Küçük Resim

Tarih

2016

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Kure Iletisim Grubu A S

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Objective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis. Methods: Five hundred and twenty three children with ASD who applied to Dr. Sami Ulus Maternity and Children Research and Training Hospital between 2010-2015 were reviewed retrospectively. Data has been obtained from computerized hospital information system. Individuals with the diagnosis of Autism (F84.0), Atypical Autism (F84.1) and Pervasive Developmental Disorder Not Other Specified (F84.9) were screened. Results: Psychotropic medication was recommended to 28.5% of the 523 children and adolescents diagnosed with ASD. Antipsychotics were the most common drugs of choice among psychotropic medications. The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p<0.01). The rate of psychotropic drug usage in female patients was significantly high than male patients (chi(2)=6.675; p=0.01). Conclusion: The results of the present study suggest that the delay of diagnosis can be included as a factor for psychotropic medication need of patients with ASD. Nearly half of the patients have been diagnosed in the first three years of their life. For further benefits of studies in Turkey, evaluating the psychopharmacological drug prescription rate, age of diagnosis and related factors to determine the present situation of psychotropic medication in our country will be necessary.

Açıklama

Anahtar Kelimeler

autism spectrum disorder; psychopharmacology; early diagnosis; burden of medication

Kaynak

Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology

WoS Q Değeri

Q4

Scopus Q Değeri

Cilt

26

Sayı

3

Künye

Bodur Ş., Taskiran C., Işıldar Y., Alan B. E., Çetinkaya M., Kara H., Şahin M., Turgut S. (2016). Factors Affecting Burden of Psychopharmacological Medication in Patients with Autism Spectrum Disorder: The Importance of Early Diagnosis. Klinik Psikofarmakoloji Bülteni, 26(3), 273 - 277.